US › Healthcare

VivoSim Labs, Inc. (VIVS)

US · Healthcare · Biotechnology

$0.26-1.14%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$18,000

Revenue YoY

-51.4%

Net profit

$-1.3M

EPS

$-0.25

Net margin

-7,433.3%

Key statistics

Market cap

$4.0M

Forward P/E

0.0

P/B

0.54

Book value

$1.70

EPS (TTM)

$-4.87

52-week high

$5.30

52-week low

$0.26

50-day MA

$0.47

200-day MA

$1.42

Beta

1.45

Shareholding

Insiders

2.67%

Institutions

11.09%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.22%
The Goldman Sachs Group Inc	0.10%
Vanguard Capital Management, LLC	0.09%
BlackRock Inc	0.07%
Vanguard Fiduciary Trust Co	0.04%
Citigroup Inc	0.04%
Tower Research Capital LLC	0.01%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for VivoSim Labs, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.